In 2017 was created Section 32, which is appeared as VC. The leading representative office of defined VC is situated in the San Diego. The company was established in North America in United States.
Among the most popular portfolio startups of the fund, we may highlight Coinbase, Auris Health, Inc., Lime. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Software, Medical. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Section 32, startups are often financed by Founders Fund, Polaris Partners, Lux Capital. The meaningful sponsors for the fund in investment in the same round are Andreessen Horowitz, Verily, GV. In the next rounds fund is usually obtained by Andreessen Horowitz, GV, Y Combinator.
The fund was created by Bill Maris. We also calculated 2 valuable employees in our database.
Opposing the other organizations, this Section 32 works on 20 percentage points less the average amount of lead investments. The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of 50 - 100 millions dollars. When the investment is from Section 32 the average startup value is 500 millions - 1 billion dollars. The fund is generally included in 7-12 deals every year. The top activity for fund was in 2019. Considering the real fund results, this VC is 7 percentage points less often commits exit comparing to other organizations.
Related Funds
| Fund Name | Location |
| AAJ Capital LLC | - |
| Angel Capital Management | Italy, Lombardy, Milan |
| Charoen Pokphand Foods PCL | Bangkok, Krung Thep, Thailand |
| Charter School Growth Fund | Broomfield, Colorado, United States |
| Electra Invest | - |
| Frontrow Energy Technology | Aberdeen City, Dyce, United Kingdom |
| Gordon and Betty Moore Foundation | California, Palo Alto, United States |
| Hivos-Triodos Fund | - |
| KBC Japan | Fukuoka, Fukuoka Prefecture, Japan |
| Meriton Capital | - |
| New India Investment Corporation | Canada, Ontario, Toronto |
| Newcrest Mining | Australia, Melbourne, Victoria |
| Rongze Ziben | China, Guangdong, Shenzhen |
| Sapphire Lake Investment | Beijing, Beijing, China |
| Shanghai Wuqi Touzi | China, Shanghai |
| Shanghai Zhixuan Chuangtou | China, Shanghai |
| Sparkling StarCapital | Beijing, Beijing, China |
| The Oil & Gas Technology Centre | Aberdeen, Scotland, United Kingdom |
| Viola Partners | Herzliya, Israel, Tel Aviv |
| Zhuojia Huizhi Chuangtou | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Brightside Health | $33M | 26 Mar 2024 | San Francisco, California, United States | ||
Ema | $25M | 05 Mar 2024 | Mountain View, California, United States | ||
Pomelo | $40M | 17 Jan 2024 | Entre Ríos Province, Argentina | ||
Puzzle Financial | $30M | 15 Nov 2023 | San Francisco, California, United States | ||
ROME Therapeutics | $72M | 12 Sep 2023 | Cambridge, Massachusetts, United States | ||
Inceptive | $100M | 07 Sep 2023 | Palo Alto, California, United States | ||
Endor Labs | $70M | 03 Aug 2023 | - | ||
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
AltPep | $52M | 22 Jun 2023 | Washington, United States |
– ROME Therapeutics announced the completion of a $77m Series B financing round.
– The round was led by new investor Section 32 and included participation from Sanofi Ventures, Casdin Capital, Andreessen Horowitz and Alexandria Venture Investments.
– ROME’s mission is to harness the power of the repeatome – the roughly 60% of the human genome consisting of repetitive sequences of nucleic acids, known as repeats – to discover powerful new classes of medicines for cancer and autoimmune diseases.
– ROME has identified multiple repeatome-derived targets and created an internal data science platform, called repeatomics, to analyze vast quantities of data available through the repeatome.
– Syllable announced a $28m Series B funding round to modernize customer service in healthcare.
– The round was led by Oak HC/FT with participation from previous investor Section 32 and will be utilized to scale partnerships with health systems, deploy with payers, and grow the team.
– Currently, most consumer-facing industries offer a digital-first customer service experience that relies primarily on self-service options. Healthcare is different, with eight out of nine people choosing to contact their healthcare provider on the phone. Yet, callers often face long call hold times, endless transfers and dead ends.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Brightside Health | $33M | 26 Mar 2024 | San Francisco, California, United States | ||
Ema | $25M | 05 Mar 2024 | Mountain View, California, United States | ||
Pomelo | $40M | 17 Jan 2024 | Entre Ríos Province, Argentina | ||
Puzzle Financial | $30M | 15 Nov 2023 | San Francisco, California, United States | ||
ROME Therapeutics | $72M | 12 Sep 2023 | Cambridge, Massachusetts, United States | ||
Inceptive | $100M | 07 Sep 2023 | Palo Alto, California, United States | ||
Endor Labs | $70M | 03 Aug 2023 | - | ||
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
AltPep | $52M | 22 Jun 2023 | Washington, United States |
